Skip to main content
. 2020 Sep 14;27(1):1301–1307. doi: 10.1080/10717544.2020.1818881

Figure 3.

Figure 3.

Plasmatic apatinib (ng/mL) curves of apatinib after treatment in the CBAPA and APA group.